Analyse-Technique.net - Toutes les news de l'analyse technique

Categories


Tags

celgene,novartis,sue,sun,pharma,on,para,iv,infringement,of,its,extended,release,adhd,drug,focalin Celgene, Novartis sue Sun Pharma on Para IV infringement of its extended release ADHD drug, Focalin
The US-based Celgene Corporation and the Swiz pharma major Novartis AG have filed a Para IV patent infringement suit against the US subsidiary of the Mumbai-based Sun Pharmaceuticals Industries Ltd with the District Court of New Jersey for allegedly attempting to manufacture and sell the generic version of extended release Focalin, used for the treatment of Attention Deficit Hyperactivity ...
2010-07-14 - PharmaBiz